Ahmed Taher Mahmoud

Ahmed Taher Mahmoud

Auto-generated profile, based on publicly available information

Ahmed Taher Mahmoud

Cairo University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in American Journal of Infection Control
Verified
Journal Article
Closed access
RYReham H.A. Yousef
Reham H.A. Yousef
MSMarwa Rashad Salem
Marwa Rashad Salem
AMAhmed Taher Mahmoud
Ahmed Taher Mahmoud

1 December 2023 in International Journal of Public Health Science (IJPHS)
Verified
Journal Article
Open access
PDF file
MSMarwa Rashad Salem
Marwa Rashad Salem
EHEman Fouad Abdel Hameed
Eman Fouad Abdel Hameed
AMAhmed Taher Mahmoud
Ahmed Taher Mahmoud
MFMohamed Fathy
Mohamed Fathy
ATAhmed Tammam
Ahmed Tammam
MZMarwa Zein
Marwa Zein
In the fight against COVID-19, the mass usage of broad-spectrum antibiotics and steroids may result in the development or worsening of a pre-existing fungal disease. The researchers conducted the current study among a sample of the general population in Egypt to assess their mucormycosis-related knowledge. The current work was an exploratory cross-sectional study performed via an online survey. The investigators conducted a convenience sampling by looking for large-networked groups on Facebook; 473 completed the questionnaire. It included: socio-demographics, 28 knowledge questions addressing definition, risk factors, modes of transmission, symptoms, and prevention of mucormycosis, and sources of knowledge. The median total knowledge percent score was 58 (9-38). The least median percent score was 25 (0-83) for prevention knowledge. The comparison between knowledge percent score and participants' demographics showed no statistically significant difference. However, the participants working in the medical field had a higher median knowledge percent score, with a p-value <0.05. The major sources of information were cited as being the internet and social media. Despite being educated, and most of the enrolled individuals were university graduates, most participants had insufficient mucormycotic knowledge. This emphasizes the importance of conducting mucormycosis awareness campaigns for the public.

1 January 2017 in Kasr Al Ainy Medical Journal
Verified
Journal Article
Closed access
PDF file
AMAhmed T Mahmoud
Ahmed T Mahmoud
MAMohammed M Abbas
Mohammed M Abbas
MEMoataz M El-Hallag
Moataz M El-Hallag
KMKhaled H Mohammed
Khaled H Mohammed
HAHesham Abd El-Monem Al-Aasar
Hesham Abd El-Monem Al-Aasar
Introduction Catheter ablation has emerged as effective therapy for AF. Ablation of AF is often a complex and long procedure requiring long fluoroscopy time. An important complication of AF ablation is the delayed effect of the radiation received by the patients and operator. Objective We conducted this prospective observational cohort to study factors associated with long fluoroscopy time during catheter ablation of AF. Patients and Method This is a prospective observational cohort study, conducted between January 2013 and January 2014 in Critical Care Medicine Department – Cairo University. Patients with symptomatic, drug refractory AF were enrolled. All patients underwent pulmonary vein isolation ± left atrial ablation according to AF type. All operators performed at least 50 previous AF ablation procedures. Clinical (AF type and LA geometry and diameter), and technical (Mapping system and catheters) variables were recorded for each patient. The primary endpoint was to identify variables associated with long fluoroscopy time. Secondary endpoints included identification of complications. Results Thirty-one patients with paroxysmal (n=25) and persistent (n=6) AF were enrolled. Pulmonary vein isolation was achieved in all patients. Average fluoroscopy time was 54.2 ± 31.7 mins. We found that the use of CARTO3® system was associated with significantly shorter fluoroscopy time compared to NavX EnSite Velocity® system (48 ± 29.8 vs. 78 ± 27.9 mins, P = 0.02). Using 20-pole circular mapping catheter was also associated with shorter fluoroscopy time as opposed to 10-pole one (47.6 ± 23.2 vs. 98.8 ± 48.4 mins, P = 0.03). Only two patients (6.4%) suffered major complications; major groin bleeding and pericardial tamponade. Conclusion The use of CARTO3® navigation system and 20-pole circular mapping catheter seems seems to be associated with shorter fluoroscopy time than EnSite Velocity® navigation system and 10-pole circular mapping catheter.

1 January 2017 in Kasr Al Ainy Medical Journal
Verified
Journal Article
Closed access
PDF file
AMAhmed T Mahmoud
Ahmed T Mahmoud
MAMohammed M Abbas
Mohammed M Abbas
MEMoataz M El-Hallag
Moataz M El-Hallag
KMKhaled H Mohammed
Khaled H Mohammed
HAHesham A.E Al-Aasar
Hesham A.E Al-Aasar
Introduction Atrial fibrillation (AF) represents an important public health problem. Catheter ablation has emerged as effective therapy. Recurrence after ablation is still around 20–40%. The long-term use of anti-arrhythmic drugs (AAD) after AF ablation has been traditionally reported to reduce late AF recurrences; but has never been supported by randomised trials. Objective To test if routine continuation of the previously unsuccessful AAD beyond blanking period reduces AF recurrence at one year after AF ablation. Patients and method This randomised controlled clinical trial was conducted between January 2013 and January 2015 in Critical Care Medicine Department – Cairo University. Patients with symptomatic, drug refractory AF were enrolled. All patients underwent pulmonary vein isolation ± left atrial ablation according to AF type. The previously unsuccessful AAD was continued for at least 3 months after ablation, after which patients were randomised to either continue or stop that drug. Patients were regularly followed up for at least additional 9 months. The primary endpoint was reduction of AF recurrence. Secondary endpoints included identification of predictors of recurrence and rate of complications. Results Thirty-one patients with paroxysmal (80.6%) and persistent (19.4%) AF were enrolled. Pulmonary vein isolation was achieved in all patients. Seventeen patients were randomized to continue AAD (54.8%) beyond blanking period. After 12 months, there was no statistically significant difference of AF recurrence between the two groups (35.3% vs. 21.4%, P=0.46). The same was observed for paroxysmal AF patients (30.8% vs. 8.3%, P=0.32). Persistent AF and early AF recurrence were associated with late recurrence. Only 2 patients had major complications. Conclusion Routine continuation of previously unsuccessful AAD did not reduce AF recurrence, over a period of 12 months. Persistent AF and recurrence during blanking period were associated with later recurrence.